ZBH
Zimmer Biomet Holdings, Inc.
NYSE · Healthcare · Medical - Devices · US
$98.07
−0.86%Sep 3, 2026, 18:45 UTC
Zimmer Biomet will relocate its global headquarters to 1800 W. Center Street in Warsaw, the largest orthopedic manufacturing facility in the world.
Source:Sep 3, 2026, 18:45 UTC
Zimmer Biomet donates its world headquarters building at 345 E. Main Street in Warsaw to Grace College, with ownership transferring in early 2027.
Source:Aug 28, 2026, 20:15 UTC
Zimmer Biomet Holdings announced that its Board of Directors approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
Source:Aug 5, 2026, 19:45 UTC
Zimmer Biomet expects to launch the full market release of its Rosa Shoulder product in the coming weeks.
Source:Aug 5, 2026, 00:00 UTC
Zimmer Biomet Holdings, Inc. reported its second quarter 2026 financial results, with net sales of $2.177 billion, net earnings of $198.3 million, and diluted EPS of $1.03.
Aug 5, 2026, 00:00 UTC
Zimmer Biomet Holdings, Inc. announced a share repurchase program of up to $1 billion for fiscal 2026.
Jul 28, 2026, 16:00 UTC
Zimmer Biomet secured $2.75 billion through two new revolving credit agreements in June 2026.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet signed an agreement to acquire Embody, an orthobiologics company, for $155 million.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet completed its acquisition of Paragon 28, a medical device company in the foot-and-ankle orthopedic sector, for about $1.1 billion.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet entered into a definitive agreement to acquire Monogram Technologies, an orthopedic robotics company, for $177 million.
Source:Jul 21, 2026, 23:59 UTC
Zimmer Biomet filed a federal lawsuit against former executive Kristoff Goson for alleged breach of confidentiality and non-compete agreement and misappropriation of trade secrets.
Source:Jul 14, 2026, 11:00 UTC
Zimmer Biomet Holdings named Chintan Desai as president of its Asia Pacific Region, effective immediately.
Source:Jul 2, 2026, 09:37 UTC
Zimmer Biomet plans to hire 500 employees over three years for its newly opened technology centre in Bengaluru, India.
Source:Jul 1, 2026, 14:30 UTC
Pacira Pharmaceuticals is selling its iovera business to Zimmer Biomet in a deal valued at up to $140 million.
Source:Jul 1, 2026, 00:00 UTC
Omnicell, Inc. appointed Nnamdi Njoku as President and Chief Operating Officer, effective June 2026.
Source:Jun 30, 2026, 00:00 UTC
Pacira BioSciences agreed to divest its Pacira CryoTech subsidiary and related cryoanalgesia device assets to Zimmer, Inc. for up to $140 million.
Source: